Clinical Trial Update: Vaginal Administration of ALA vs Progesterone for the Subchorionic Hematoma Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vaginal aminolevulinic acid to progesterone for subchorionic hematoma in early pregnancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Abortion
• Subchorionic Hematoma

Drugs mentioned

• PROGESTERONE (Progesterone)
• aminolevulinic acid (ALA) (aminolevulinic acid)

Snippet

Sponsor: Azienda USL Ferrara | Conditions: Subchorionic Hematoma in the First Trimester Pregnancy, Miscarriage | Phase 4 | Status: COMPLETED